EP0142426A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Ophthalmic formulation containing norfloxacin and related antibiotics
Assignee: Merck and Co Inc
•
Filing: 1984-11-06
•
Granted: —
•
Expires: 2004-11-06
Abstract
Abstract Norfloxacin and related antibiotics are useful in the treatment of ocular infections by topical administration.
Inventors
- 👤 Irving M. Katz
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-08 05:30
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K9/00; A61K9/0012; A61K9/0048; A61P; A61P27/00; A61P27/02
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
32 words
An ophthalmic antibiotic formulation comprising an ophthalmologically acceptable carrier and an effective antibiotic amount of an antibiotic selected from norfloxacin, ofloxacin, pefloxacin, AT-2266 and Bayer 09867, hydrates or ophthalmologically acceptable salts thereof.
Claim 2
Dependent Claim
32 words
An ophthalmic antibiotic formulation comprising an ophthalmologically acceptable carrier and an effective antibiotic amount of an antibiotic selected from norfloxacin, ofloxacin, pefloxacin, AT-2266 and Bayer 09867, hydrates or ophthalmologically acceptable salts thereof.
Claim 3
Dependent Claim
17 words
The formulation of Claim 1 wherein the antibiotic is norfloxacin, a hydrate or ophthalmologically acceptable salt thereof.
Claim 4
Dependent Claim
19 words
The formulation of Claim 2 wherein the carrier is an aqueous solution comprising norfloxacin, sodium acetate, and ethylenediaminetetraacetic acid.
Claim 5
Dependent Claim
12 words
The formulation of Claim 2 wherein the carrier is a thermal gel.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.